Deal Details
Follow-On Offering
Summary
Baird served as a co-manager on this offering
About
BioMed Realty Trust, Inc. (NYSE: BMR) (“BioMed” or the “Company”) recently completed a follow-on offering of 14,605,000 common shares at a price of $20.50 per share, generating gross proceeds of approximately $299.4 million. BioMed intends to use the net proceeds from this offering to fund a property acquisition, to fund a portion of the redemption of the Company’s Series A preferred stock, to repay a portion of the outstanding indebtedness under its unsecured line of credit and for other general corporate and working capital purposes.BioMed is a self-advised real estate investment trust that delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in properties comprising approximately 13.1 million rentable square feet. The Company’s properties are located predominantly in the major U.S. life science markets of Boston, San Francisco, Maryland, San Diego, New York/New Jersey, Pennsylvania and Seattle, which have well-established reputations as centers for scientific research. BioMed is headquartered in San Diego, California.
For additional information about this transaction, please contact:
- Date
- February 2013
- Company
- BioMed Realty Trust, Inc.
- Transaction
- M&A
- Sectors
- Real Estate
- Target Geography
- North America
Share
